Orchid logo — We help couples have healthy babies.

Orchid

We help couples have healthy babies.

Founded 2020 United States San Francisco, United States 46 employees Seed Total: $16.50M Biotechnology, Digital Health +1

General Information

Company Name Orchid
Founded Year 2020
Location United States San Francisco, United States
Employees 46
Industries Biotechnology, Digital Health, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Orchid. To contact Orchid, visit orchidhealth.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Orchid

Orchid is a biotechnology and healthcare startup founded in 2019, based in the United States. The company's mission, encapsulated in their slogan "We help couples have healthy babies," revolves around providing a new superpower to parents. This power comes in the form of safely and naturally mitigating genetic risks in their future child using Orchid's innovative solutions. The company recently secured a significant milestone, receiving a $12.00M Seed Round investment on 05 December 2023. The noteworthy investors participating in this round include Conviction Capital, Elad Gil, Pebblebed, Prometheus Fund, Anne Wojcicki, Mario Schlosser, Brian Armstrong, Starbloom Capital, Fidji Simo, Dylan Field. Orchid's commitment to revolutionizing prenatal care and genetics positions them as a promising venture for potential investors. For more information, interested parties can sign up at www.orchidhealth.com.

Taxonomy: reproductive technology, genetic testing, preconception care, genetic predispositions, rare genetic disorders, genome analysis, biomarker monitoring, in vitro fertilization, genetic risk assessment, genetic counseling, personalized medicine

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $12.00M 10
Elad Gil, Pebblebed +8
05 Dec 2023
Seed Round Undisclosed -
31 Aug 2022
Seed Round $4.50M -
07 Apr 2021

Orchid Alternatives & Competitors

View All Alternatives
Orchid vs
Variantyx
Variantyx United States

Variantyx is a technology-driven precision medicine company providing state-of-the-art genomic testi...

Series D
221 employees
Biotechnology, Health Care
Orchid vs

Discover the future of genomics with ultra-sensitive and ultra-specific DNA structural variation det...

Post-IPO Equity
201-500 employees
Biotechnology, Health Care
Orchid vs
CENTOGENE
CENTOGENE Germany

Empowering precision medicine through advanced diagnosis 

IPO
475 employees
Biotechnology, Health Care

FAQ About Orchid

We help couples have healthy babies.
Orchid was founded in 2020.
Orchid is headquartered in San Francisco, United States.
Orchid operates in Biotechnology, Digital Health and Health Care. Its work centres on reproductive technology, genetic testing, preconception care and genetic predispositions.
Orchid has approximately 46 employees.
Orchid has completed 3 funding rounds, raising a total of $16.50M. The latest funding stage is Seed.
Top alternatives and competitors to Orchid include Variantyx, Bionano Genomics, CENTOGENE, Pinnacle Washington, Inbiomotion. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orchid and Variantyx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orchid, https://bouncewatch.com/company/orchid-1, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes